With the super-contagious omicron variants getting better at dodging protection, the FDA decided boosters needed an update.
They found adding the extra protection was safe — and spurred production of more omicron-fighting antibodies than just getting another dose of today’s vaccine.
“We’re continuing to collect more data from our study on BA.4/5 and will be in touch as soon as we are ready to submit,” Pfizer spokeswoman Jerica Pitts said in an emailed message.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Tweaked COVID boosters in US must target newer omicron typesU.S. regulators are telling COVID-19 vaccine makers to tweak any booster doses intended for fall so they protect against the newest omicron relatives
Baca lebih lajut »
Pfizer signs new $3.2 billion COVID vaccine deal with U.S. governmentPfizer Inc and partner BioNTech SE said on Wednesday they signed a $3.2 billion deal with the U.S. government for 105 million doses of their COVID-19 vaccine, which could be delivered as soon as later this summer.
Baca lebih lajut »
Pfizer Seeks FDA’s Full Approval for Paxlovid Covid-19 PillApproval of Paxlovid, which has been available under an Food and Drug Administration authorization for use during the pandemic, would allow Pfizer to market and sell it commercially.
Baca lebih lajut »
U.S. FDA will decide on redesigned COVID vaccines by early JulyU.S. regulators plan to decide by early July whether to change the design of COVID-19 vaccines this fall in order to combat more recent variants of the coronavirus, with hopes of launching a booster campaign by October, a top Food and Drug Administration official said on Tuesday.
Baca lebih lajut »
U.S. Supply of Effective Covid Antibody Drug DwindlingThe last doses of the drug, one of a few found to reduce the risk of severe disease even after Omicron, will be used up in late August unless Congress approves more pandemic funding, administration officials say.
Baca lebih lajut »